Overcoming cancer therapeutic bottleneck by drug repurposing Z Zhang, L Zhou, N Xie, EC Nice, T Zhang, Y Cui, C Huang Signal transduction and targeted therapy 5 (1), 113, 2020 | 441 | 2020 |
Redox signaling and unfolded protein response coordinate cell fate decisions under ER stress Z Zhang, L Zhang, L Zhou, Y Lei, Y Zhang, C Huang Redox biology 25, 101047, 2019 | 264 | 2019 |
Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma Y Chen, HN Chen, K Wang, L Zhang, Z Huang, J Liu, Z Zhang, M Luo, ... Journal of hepatology 70 (1), 66-77, 2019 | 129 | 2019 |
Guidelines for the use and interpretation of assays for monitoring autophagy 1 D Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... Autophagy 17 (1), 1-382, 2021 | 69 | 2021 |
Redox signaling at the crossroads of human health and disease J Zuo, Z Zhang, M Luo, L Zhou, EC Nice, W Zhang, C Wang, C Huang MedComm 3 (2), e127, 2022 | 62 | 2022 |
Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities Z Huang, Z Zhang, C Zhou, L Liu, C Huang MedComm 3 (2), e144, 2022 | 61 | 2022 |
Circadian rhythms and cancers: the intrinsic links and therapeutic potentials L Zhou, Z Zhang, E Nice, C Huang, W Zhang, Y Tang Journal of Hematology & Oncology 15 (1), 21, 2022 | 60 | 2022 |
Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA L Zhou, J Jiang, Z Huang, P Jin, L Peng, M Luo, Z Zhang, Y Chen, N Xie, ... Molecular cancer 21 (1), 168, 2022 | 56 | 2022 |
Inhibition of NPC1L1 disrupts adaptive responses of drug‐tolerant persister cells to chemotherapy Z Zhang, S Qin, Y Chen, L Zhou, M Yang, Y Tang, J Zuo, J Zhang, ... EMBO molecular medicine 14 (2), e14903, 2022 | 52 | 2022 |
Repurposing brigatinib for the treatment of colorectal cancer based on inhibition of ER-phagy Z Zhang, W Gao, LI Zhou, Y Chen, S Qin, LU Zhang, J Liu, Y He, Y Lei, ... Theranostics 9 (17), 4878, 2019 | 50 | 2019 |
Autophagy in health and disease: From molecular mechanisms to therapeutic target G Lu, Y Wang, Y Shi, Z Zhang, C Huang, W He, C Wang, HM Shen MedComm 3 (3), e150, 2022 | 46 | 2022 |
ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of Fusobacterium nucleatum in Colorectal Cancer X Zheng, R Liu, C Zhou, H Yu, W Luo, J Zhu, J Liu, Z Zhang, N Xie, ... Cancer Research 81 (24), 6157-6170, 2021 | 46 | 2021 |
The multifaceted role of flavonoids in cancer therapy: leveraging autophagy with a double-edged sword Z Zhang, J Shi, EC Nice, C Huang, Z Shi Antioxidants 10 (7), 1138, 2021 | 40 | 2021 |
Proteomics, personalized medicine and cancer M Su, Z Zhang, L Zhou, C Han, C Huang, EC Nice Cancers 13 (11), 2512, 2021 | 39 | 2021 |
Brefeldin A inhibits colorectal cancer growth by triggering Bip/Akt‐regulated autophagy L Zhou, W Gao, K Wang, Z Huang, L Zhang, Z Zhang, J Zhou, EC Nice, ... The FASEB Journal 33 (4), 5520-5534, 2019 | 35 | 2019 |
Carrier-free nanoplatform via evoking pyroptosis and immune response against breast cancer L Li, H Tian, Z Zhang, N Ding, K He, S Lu, R Liu, P Wu, Y Wang, B He, ... ACS applied materials & interfaces 15 (1), 452-468, 2022 | 34 | 2022 |
The crosstalk between reactive oxygen species and noncoding RNAs: From cancer code to drug role J Zuo, Z Zhang, M Li, Y Yang, B Zheng, P Wang, C Huang, S Zhou Molecular Cancer 21 (1), 30, 2022 | 28 | 2022 |
Noncoding RNAs in tumor metastasis: molecular and clinical perspectives QL Liu, Z Zhang, X Wei, ZG Zhou Cellular and Molecular Life Sciences, 1-28, 2021 | 24 | 2021 |
Repurposing antifungal drugs for cancer therapy N Weng, Z Zhang, Y Tan, X Zhang, X Wei, Q Zhu Journal of Advanced Research 48, 259-273, 2023 | 19 | 2023 |
Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis P Jin, J Jiang, L Zhou, Z Huang, S Qin, HN Chen, L Peng, Z Zhang, B Li, ... EMBO Molecular Medicine 14 (12), e16082, 2022 | 19 | 2022 |